Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04968249 · ClinicalTrials.gov registry record
Michigan Early Disease Progression Cohort
A clinical trial of COPD, sponsored by University of Michigan.
- Active
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04968249: Active study of COPD, sponsored by University of Michigan.
NCT04968249 is a study of COPD that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 200 participants, below the 2,416-participant average among 85 other COPD trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04968249, a study of COPD, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this project is to develop a disease progression cohort within the University of Michigan Health System to capture pulmonary function, symptom assessments and quantitative imaging among patients at risk for or with an established diagnosis of COPD, focusing however on "early" COPD (age 30-55 and GOLD stage 0,1, 2, and prism).
Primary Outcome
Proportion of individuals with CAAT score ≥ 10
Conditions Studied
Interventions
- OTHER Observational
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-07-30 |
| Est. Completion | 2027-03 |
What the registry record for NCT04968249 still lists
NCT04968249 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,416-participant average among 85 other COPD trials with a reported enrollment target (92% lower).
The record links to 1 condition, with COPD appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.
NCT04968249 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT04968249 about?
NCT04968249 is a clinical study titled "Michigan Early Disease Progression Cohort". The aim of this project is to develop a disease progression cohort within the University of Michigan Health System to capture pulmonary function, symptom assessments and quantitative imaging among patients at risk for or with an established diagnosis of COPD, focusing however on "early" COPD (age 30...
What is the current status of trial NCT04968249?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2021-07-30. Estimated completion is 2027-03.
What conditions does trial NCT04968249 study?
This clinical trial studies the following conditions: COPD.
What interventions are being tested in trial NCT04968249?
The interventions under investigation include: Observational (OTHER).
Who is sponsoring clinical trial NCT04968249?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04968249 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COPD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04968249's enrollment target sits among peer trials
200 30th of 85 higher than 55 of 85 other COPD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COPD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
RECRUITING · NA
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Relationship of Inflammation and Pulmonary Function to Fungal Translocation in HIV
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI